Mangoceuticals (MGRX) Total Current Liabilities (2022 - 2026)
Mangoceuticals recorded quarterly Total Current Liabilities of $737606.0 in Q1 2026, down 17.18% quarter-over-quarter from $890568.0 in Q4 2025, and down 50.93% year-over-year from $1.5 million in Q1 2025.
Mangoceuticals' Total Current Liabilities history runs 5 years deep, the most recent figure standing at $737606.0 for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 50.93% year-over-year to $737606.0; the TTM figure through Mar 2026 stood at $737606.0 (down 50.93% YoY), while the FY2025 annual figure was $890568.0, down 37.52% from the prior year.
- Total Current Liabilities came in at $737606.0 for Q1 2026 at Mangoceuticals, down from $890568.0 in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.6 million in Q2 2025 to a low of $159176.0 in Q3 2023.
- A 5-year average of $853861.2 and a median of $847421.5 in 2025 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities soared 774.12% in 2024 and plunged 50.93% in 2026, its largest moves.
- Mangoceuticals' Total Current Liabilities stood at $260577.0 in 2022, then retreated by 19.0% to $211078.0 in 2023, then jumped by 575.33% to $1.4 million in 2024, then slumped by 37.52% to $890568.0 in 2025, then decreased by 17.18% to $737606.0 in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $737606.0, $890568.0, and $804275.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 1.64 Bn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 1.55 Bn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 135.74 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 414.48 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 154.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 219.96 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 113.60 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 601.30 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 483.05 Mn |
| 10 | Mangoceuticals | 7.03 Mn | 6.84 Mn | 29,001.00 | 737,606.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 737,606.00 |
| Dec 31, 2025 | 890,568.00 |
| Sep 30, 2025 | 804,275.00 |
| Jun 30, 2025 | 1.60 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 1.43 Mn |
| Sep 30, 2024 | 1.39 Mn |
| Jun 30, 2024 | 1.38 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | 211,078.00 |
| Sep 30, 2023 | 159,176.00 |
| Jun 30, 2023 | 196,482.00 |
| Mar 31, 2023 | 182,842.00 |
| Dec 31, 2022 | 260,577.00 |